DEVELOPING: Kimberly-Clark Acquires Kenvue in Multi-Billion Dollar Deal

Breaking News: Kimberly-Clark Acquires Kenvue in Multi-Billion Dollar Deal Kimberly-Clark, the US-based consumer goods company behind Huggies diapers and Kleenex tissues, has agreed to acquire Kenvue, the manufacturer of Tylenol and Band-Aids, in a deal worth nearly $49 billion. The acquisition was announced on November 3, 2025. The deal adds a significant portfolio of consumer brands to Kimberly-Clark's existing lineup, including Tylenol, Band-Aid, Listerine, Neutrogena, and Aveeno. The acquisition is expected to create a global health and wellness leader, according to Kimberly-Clark CEO Mike Hsu. Kenvue has faced controversy in recent times, with the Trump administration linking the active ingredient in Tylenol, acetaminophen, to autism. However, Kenvue has denied these claims, stating they are unfounded. The acquisition is set to be completed in the coming months, pending regulatory approvals. This is a significant development in the consumer goods industry, and its impact will be closely watched in the coming days. This is a developing story, and we will provide updates as more information becomes available.